Class Action Lawsuits | List Of Open Cases, Settlements
Empower the People, Hold Companies Accountable. Empowerment starts with knowledge. We provide accurate, up-to-date information about products you buy, services you use and medications and medical devices you depend on.
Actived: Saturday Mar 6, 2021
Class Action Lawsuit Against Opioid Manufacturers | Class
One company in particular, Purdue Pharma, maker of OxyContin, exemplified the industry’s focus on chronic non-cancer pain. OxyContin was approved in 1995.From 1996 to 2002, OxyContin sales increased from 300,000 prescriptions ($44 million) to 7.2 million prescriptions ($1.5 billion).
Victims Look for Answers as Opioid Epidemic Sweeps America
Branded promotional materials—including hats, plush toys, coffee mugs, and coupons for free OxyContin prescriptions—were distributed to practitioners. Purdue also conducted “pain conferences” where physicians gave paid speeches and targeted doctors with medical journal advertisements.
Drugs Archives - Page 2 of 2 - Page 2 of 2 - ClassAction.com
The drugs are approved to treat type 2 diabetes, but doctors are free to prescribe drugs for off-label (non-FDA approved) uses such as type 1 diabetes. “People with type 1 diabetes who use an SGLT-2 inhibitor are at increased risk for DKA, which appears to be dose related,” Dr. Peters told Endocrine Today .